21 September 2015 - Deborah Wilkes
Archived
Perrigo's Board of Directors has "unanimously" rejected Mylan's takeover offer, stating that it "substantially undervalues the company and does not adequately compensate shareholders for Perrigo's exceptional standalone growth prospects".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.